We are live on ! Find out more
CRL icon

Charles River Laboratories

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47%94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 157 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
76
Lord, Abbett & Co
New Jersey
$30.3M -$1.5M -4,880 -4%
AllianceBernstein
77
AllianceBernstein
Tennessee
$30M +$12.1M +39,361 +59%
CCMG
78
Clark Capital Management Group
Pennsylvania
$29.8M +$14.2M +45,994 +78%
CIBC Private Wealth Group
79
CIBC Private Wealth Group
Georgia
$29.4M +$773K +2,508 +2%
California Public Employees Retirement System
80
California Public Employees Retirement System
California
$28.7M -$2.34M -7,595 -7%
BTW
81
Boston Trust Walden
Massachusetts
$28.1M +$4.45M +14,431 +17%
Stifel Financial
82
Stifel Financial
Missouri
$27M +$1.66M +5,375 +6%
SEI Investments
83
SEI Investments
Pennsylvania
$27M +$340K +1,104 +1%
IHL
84
Investment House LLC
California
$25.7M -$307K -995 -1%
California State Teachers Retirement System (CalSTRS)
85
California State Teachers Retirement System (CalSTRS)
California
$23.6M -$1.59M -5,152 -6%
SCM
86
Sandler Capital Management
New York
$23.4M +$18M +58,227 +241%
Skandinaviska Enskilda Banken (SEB)
87
Skandinaviska Enskilda Banken (SEB)
Sweden
$22.9M +$3.15M +10,207 +14%
Point72 Asset Management
88
Point72 Asset Management
Connecticut
$22.3M +$543K +1,761 +2%
LCM
89
Lakewood Capital Management
New York
$21.9M +$23.8M +77,100 New
NPF
90
Norris Perne & French
Michigan
$21.3M +$525K +1,701 +2%
IAM
91
Iridian Asset Management
Connecticut
$21.2M +$4.93M +15,974 +27%
Qube Research & Technologies (QRT)
92
Qube Research & Technologies (QRT)
United Kingdom
$20.9M +$9.7M +31,447 +74%
MPIA
93
Mountain Pacific Investment Advisers
Idaho
$20.9M +$296K +959 +1%
RhumbLine Advisers
94
RhumbLine Advisers
Massachusetts
$20.9M -$3.73M -12,085 -14%
CS
95
Candriam SCA
Luxembourg
$19.2M -$19.4M -62,879 -48%
New York State Teachers Retirement System (NYSTRS)
96
New York State Teachers Retirement System (NYSTRS)
New York
$18.9M -$347K -1,124 -2%
KCM
97
Kornitzer Capital Management
Kansas
$18.9M
GLA
98
Great Lakes Advisors
Illinois
$18.4M -$6.17M -20,005 -24%
Principal Financial Group
99
Principal Financial Group
Iowa
$18M -$708K -2,296 -4%
New York State Common Retirement Fund
100
New York State Common Retirement Fund
New York
$17.8M +$485K +1,573 +3%

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.